DNA Script

Biotechnology · Paris, France · Founded 2014 · Privately Held (backing)

Developer of DNA printer technology designed to print synthetic nucleic acids for genomics and molecular biology applications. DNA Script is based in Paris, France and was founded in 2014. It was valued at $660 million at its later-stage round in Jan 2022, the last priced event on record. It has raised $299 million across 1 recorded round; the latest was a $192 million Series C in Jan 2022.

PMV mark · valuation
$659.7M
Oct 2026
Priced at
its later-stage round
Jan 2022
Total raised
$298.7M
Last round
Later Stage VC (Series C)
Jan 2022
What is DNA Script worth?
$659.7MPrivateMarketView mark · Oct 2026

Valued at $659.7M at its later-stage round, Jan 2022. Nothing has traded since.

Free account
More of DNA Script with a free account
  • ·The complete investor list: 34 names
  • ·Watch DNA Script: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Valuation timeline

0 priced rounds · 32 daily marks since · Sep 2026 – Oct 2026
▮▮
Markrounds hold their value until the next priced eventMark, today
log scale
Post-money values unlock with a free account.Unlock the axis

Membership and data by Private Market View

DNA Script funding history

1 rounds
DateRoundRaisedPost-money
Jan 2022Later Stage VC (Series C)$191.7M▮
Unlock post-money valuations

Membership and data by Private Market View

DNA Script valuation

DNA Script was valued at $660 million at its later-stage round in Jan 2022. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.

How much has DNA Script raised?

DNA Script has raised $299 million in total; 1 of its rounds is on record. The largest on record was a $192 million Series C in Jan 2022.

Comparable companies

Comparable biotechnology names by valuation on PrivateMarketView: Cardurion ($760 million), Odyssey Therapeutics ($638 million) and bit.bio ($546 million).

How DNA Script's valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For DNA Script, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by its last priced round. Question about this number? Full methodology →

Frequently asked about DNA Script

What is DNA Script worth?
DNA Script is valued at $659.7M as of Oct 2026. Valued at $659.7M at its later-stage round, Jan 2022. Nothing has traded since.
How much has DNA Script raised?
DNA Script has raised $298.7M in total funding across 1 recorded rounds.
When did DNA Script last raise?
DNA Script last raised in Jan 2022 (Later Stage VC (Series C)), raising $191.7M.